CURRENT THERAPEUTIC STRATEGIES IN PEDIATRIC PFAPA SYNDROME: EFFICACY, SAFETY, AND QUALITY-OF-LIFE CONSIDERATIONS – A NARRATIVE REVIEW
DOI:
https://doi.org/10.31435/ijitss.4(52).2026.6677Keywords:
PFAPA Syndrome, Periodic Fever, Pediatric Autoinflammatory Diseases, Colchicine, Tonsillectomy, Quality of LifeAbstract
Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome is a common periodic fever disorder of childhood. Although it usually has a favorable long-term course, recurrent attacks may substantially disrupt school attendance, family life, and quality of life. This narrative review summarizes current therapeutic strategies for pediatric PFAPA, focusing on efficacy, safety, and patient-centered outcomes. A structured PubMed/MEDLINE search, supplemented by the Cochrane Library and reference screening, was used to identify relevant evidence on corticosteroids, colchicine, cimetidine, non-standard preventive therapies, interleukin-1 inhibition, and tonsil surgery. Corticosteroids are highly effective for rapid termination of acute attacks but do not prevent recurrence and may shorten attack-free intervals in some patients. Colchicine has the strongest evidence among pharmacological preventive options and can reduce attack frequency and corticosteroid use. Evidence for cimetidine, ketotifen, probiotics, and vitamin D is more limited. Tonsillectomy may lead to sustained remission and can improve quality of life and school functioning, but spontaneous remission, surgical risk, incomplete response, and recurrence must be considered. Evidence for interleukin-1 inhibition remains insufficient for routine use. Current data do not support one universally superior treatment. Management should be individualized according to attack burden, response to previous therapy, safety, quality of life, and family preferences. Better prospective comparative studies with standardized outcomes are needed.
References
Førsvoll, J., Kristoffersen, E. K., & Øymar, K. (2013). Incidence, clinical characteristics and outcome in Norwegian children with periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome; a population-based study. Acta Paediatrica, 102(2), 187–192. https://doi.org/10.1111/apa.12069
Gattorno, M., Hofer, M., Federici, S., Vanoni, F., Bovis, F., Aksentijevich, I., et al. (2019). Classification criteria for autoinflammatory recurrent fevers. Annals of the Rheumatic Diseases, 78(8), 1025–1032. https://doi.org/10.1136/annrheumdis-2019-215048
Anselmi, F., Dusser, P., & Kone-Paut, I. (2025). Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome in children—from pathogenesis to treatment strategies: A comprehensive review. Paediatric Drugs, 27(5), 575–592. https://doi.org/10.1007/s40272-025-00699-1
Grimwood, C., Kone-Paut, I., Piram, M., Rossi-Semerano, L., & Hentgen, V. (2018). Health-related quality of life in children with PFAPA syndrome. Orphanet Journal of Rare Diseases, 13(1), 132. https://doi.org/10.1186/s13023-018-0878-3
Rydenman, K., Sparud-Lundin, C., Karlsson-Bengtsson, A., Berg, S., Fasth, A., & Wekell, P. (2023). Tonsillectomy reduces the family impact of periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome and improves health-related quality of life in affected children. Orphanet Journal of Rare Diseases, 18(1), 153. https://doi.org/10.1186/s13023-023-02773-8
García-Soto, X. R., Villanueva-Alameda, M. I., Fernández-Solana, J., González-Bernal, J. J., Bernal-Jiménez, A., Santos-Martín, L., et al. (2025). Quality of life and psychological functioning in children with PFAPA syndrome. Pediatric Reports, 17(3), 51. https://doi.org/10.3390/pediatric17030051
Amarilyo, G., Rothman, D., Manthiram, K., Edwards, K. M., Li, S. C., Marshall, G. S., et al. (2020). Consensus treatment plans for periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome (PFAPA): a framework to evaluate treatment responses from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) PFAPA work group. Pediatric Rheumatology, 18(1), 31. https://doi.org/10.1186/s12969-020-00424-x
Hofer, M. (2020). Why and how should we treat periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome? Paediatric Drugs, 22(3), 243–250. https://doi.org/10.1007/s40272-020-00393-4
Dipasquale, R. F., Sinopoli, P., Mendicino, A., & Gallizzi, R. (2026). Colchicine prophylaxis in pediatric PFAPA: a systematic review. European Journal of Pediatrics, 185(1), 57. https://doi.org/10.1007/s00431-025-06726-0
Noy, R., Barzilai, R., Cohen, J. T., Gordin, A., & Zur, K. B. (2025). Surgical treatments for periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome: Systematic review and network meta-analysis. Otolaryngology–Head and Neck Surgery, 173(5), 1092–1098. https://doi.org/10.1002/ohn.1371
Alsabri, M., Rath, S., Elkarargy, M. A., Abdelwahab, O. A., Ahmed, A. H., & Alwarraqi, A. G. (2026). Surgical versus medical management of PFAPA (Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis): a systematic review and network meta-analysis. Pediatric Rheumatology. https://doi.org/10.1186/s12969-026-01242-3
Batu, E. D., Sener, S., Rodrigues, M., Vinit, C., Hofer, F., Laskari, K., et al. (2025). Corticosteroid use in PFAPA syndrome: Clinical practice data from the JIR-CliPS Survey Study and a comprehensive literature review. Rheumatology, 64(6), 3787–3796. https://doi.org/10.1093/rheumatology/keaf036
Gołuchowska, N., Tomaszewska, A., Ząber, A., Będzichowska, A., Knapik, A., Kudiuk, A., et al. (2026). Epidemiology and clinical course of PFAPA syndrome in the pediatric population—single center study. BMC Pediatrics, 26(1), 765. https://doi.org/10.1186/s12887-026-07134-5
Yazgan, H., Gültekin, E., Yazıcılar, O., Sagun, Ö. F., & Uzun, L. (2012). Comparison of conventional and low dose steroid in the treatment of PFAPA syndrome: preliminary study. International Journal of Pediatric Otorhinolaryngology, 76(11), 1588–1590. https://doi.org/10.1016/j.ijporl.2012.07.020
Feder, H. M., & Salazar, J. C. (2010). A clinical review of 105 patients with PFAPA (a periodic fever syndrome). Acta Paediatrica, 99(2), 178–184. https://doi.org/10.1111/j.1651-2227.2009.01554.x
Kalayci, F., Yigit, M., Kuruc, A. I., Cevirici, T., & Celikel Acar, B. (2025). Assessment of attack frequency in PFAPA patients based on therapeutic modalities. Journal of Paediatrics and Child Health, 61(3), 376–381. https://doi.org/10.1111/jpc.16756
Özaslan, Z., Şen, A., Atamyıldız Uçar, S., Çakan, M., Sanisoğlu, B., Kaya, F., et al. (2024). Exploring factors for predicting colchicine responsiveness in children with PFAPA. European Journal of Pediatrics, 183(10), 4337–4343. https://doi.org/10.1007/s00431-024-05703-3
Bagrul, İ., Arslanoglu Aydin, E., Tuncez, S., Baglan, E., Özdel, S., & Bülbül, M. (2024). Effect of colchicine treatment on clinical course in children with PFAPA syndrome. Klinische Pädiatrie, 236(5), 296–300. https://doi.org/10.1055/a-2274-9046
Koru, L., Yabanci Erten, E. S., Dursun, H. K., Dizman, E. N., Kaya, F., Kucuk, E., et al. (2025). Colchicine treatment in PFAPA: how long should we wait for the clinical response? European Journal of Pediatrics, 184(5), 322. https://doi.org/10.1007/s00431-025-06158-w
Raeeskarami, S. R., Sadeghi, P., Vahedi, M., Asna Ashari, K., Mousavi, T. M., & Ziaee, V. (2022). Colchicine versus cimetidine: the better choice for Periodic fever, aphthous stomatitis, pharyngitis, adenitis (PFAPA) syndrome prophylaxis, and the role of MEFV gene mutations. Pediatric Rheumatology, 20(1), 72. https://doi.org/10.1186/s12969-022-00733-3
AliSliman, R. K., Regev, S., Ghanim, B., & Hamad Saied, M. (2026). Colchicine prophylaxis efficacy in PFAPA syndrome: A comparative cohort study. Seminars in Arthritis and Rheumatism, 77, 152941. https://doi.org/10.1016/j.semarthrit.2026.152941
Welzel, T., Ellinghaus, M., Wildermuth, A. L., Deschner, N., Benseler, S. M., & Kuemmerle-Deschner, J. B. (2021). Colchicine effectiveness and safety in periodic fever, aphthous stomatitis, pharyngitis, and adenitis. Frontiers in Pediatrics, 9, 759664. https://doi.org/10.3389/fped.2021.759664
Ohnishi, T., Sato, S., Uejima, Y., Kawano, Y., & Suganuma, E. (2022). Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome: Clinical characteristics and treatment outcomes—a single center study in Japan. Pediatrics International, 64(1), e15294. https://doi.org/10.1111/ped.15294
Kapustova, L., Banovcin, P., Bobcakova, A., Jurkova Malicherova, E., Kapustova, D., Petrovicova, O., et al. (2023). The use of ketotifen as long-term anti-inflammatory prophylaxis in children with PFAPA syndrome. Frontiers in Immunology, 14, 1302875. https://doi.org/10.3389/fimmu.2023.1302875
La Torre, F., Sota, J., Insalaco, A., Conti, G., Del Giudice, E., Lubrano, R., et al. (2023). Preliminary data revealing efficacy of Streptococcus salivarius K12 (SSK12) in PFAPA syndrome: A multicenter study from the AIDA Network PFAPA syndrome registry. Frontiers in Medicine, 10, 1105605. https://doi.org/10.3389/fmed.2023.1105605
Spagnolo, A., Mileto, V., Civino, A., Maggio, M. C., Risso, P., Sestito, S., & Gallizzi, R. (2024). Use of Streptococcus salivarius K12 in a cohort of PFAPA patients. Frontiers in Pediatrics, 12, 1370544. https://doi.org/10.3389/fped.2024.1370544
Yabanci Erten, E. S., Koru, L., Kaya, F., Kucuk, E., Aydin, Z., Dizman, E. N., et al. (2026). Evaluation of clinical responses to probiotics and colchicine in PFAPA patients based on autoinflammatory diseases activity index (AIDAI) scores. Pediatric Research. https://doi.org/10.1038/s41390-026-04809-8
Faydhi, S. A., Kanawi, H. M. A., Al-Khatib, T., & Zawawi, F. (2022). The association between vitamin D level and PFAPA syndrome: A systematic review. Indian Journal of Otolaryngology and Head & Neck Surgery, 74(Suppl 3), 5548–5555. https://doi.org/10.1007/s12070-021-02913-1
Stojanov, S., Lapidus, S., Chitkara, P., Feder, H., Salazar, J. C., Fleisher, T. A., et al. (2011). Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) is a disorder of innate immunity and Th1 activation responsive to IL-1 blockade. Proceedings of the National Academy of Sciences of the United States of America, 108(17), 7148–7153. https://doi.org/10.1073/pnas.1103681108
Soylu, A., Yıldız, G., Torun Bayram, M., & Kavukçu, S. (2021). IL-1β blockade in periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome: case-based review. Rheumatology International, 41(1), 183–188. https://doi.org/10.1007/s00296-019-04389-3
Isa, M., Tiller, G. M., Liew, D. F., & Renton, W. D. (2025). Long-term safety of anti-interleukin-1 medications in children with rheumatic diseases: A systematic review. Paediatric Drugs, 27(6), 693–705. https://doi.org/10.1007/s40272-025-00712-7
Renko, M., Salo, E., Putto-Laurila, A., Saxen, H., Mattila, P. S., Luotonen, J., et al. (2007). A randomized, controlled trial of tonsillectomy in periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome. The Journal of Pediatrics, 151(3), 289–292. https://doi.org/10.1016/j.jpeds.2007.03.015
Garavello, W., Romagnoli, M., & Gaini, R. M. (2009). Effectiveness of adenotonsillectomy in PFAPA syndrome: a randomized study. The Journal of Pediatrics, 155(2), 250–253. https://doi.org/10.1016/j.jpeds.2009.02.038
Burton, M. J., Pollard, A. J., Ramsden, J. D., Chong, L. Y., & Venekamp, R. P. (2019). Tonsillectomy for periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome (PFAPA). Cochrane Database of Systematic Reviews, 12, CD008669. https://doi.org/10.1002/14651858.CD008669.pub3
Lantto, U., Tapiainen, T., Pokka, T., Koivunen, P., Helminen, M., Piitulainen, J., et al. (2024). Tonsillotomy for periodic fever syndrome: A randomized and controlled trial. Laryngoscope, 134(2), 968–972. https://doi.org/10.1002/lary.30863
Cavalcante, L. F. F., Costa, G., Battistuta, S. M., Makabe, P. F., Bueno, I. S. F., Yuamoto, B., et al. (2025). Surgical management for periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome: a systematic review and meta-analysis. Jornal de Pediatria, 101(4), 494–500. https://doi.org/10.1016/j.jped.2025.03.006
Xia, M., Chen, Y., Yang, Y., Wang, Y., Zhang, Y., Chen, J., et al. (2026). The efficacy of tonsillectomy in the management of PFAPA syndrome: a systematic review and meta-analysis. Frontiers in Surgery, 13, 1825542. https://doi.org/10.3389/fsurg.2026.1825542
Moberg, T., Rydenman, K., Berg, S., Fasth, A., & Wekell, P. (2025). Long-term symptoms in periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome after tonsillectomy. The Journal of Pediatrics, 278, 114424. https://doi.org/10.1016/j.jpeds.2024.114424
Manthiram, K., Ortega-Villa, A. M., Lapidus, S., Bowes, M., Romeo, T., Garguilo, K., et al. (2025). Features associated with response to tonsillectomy in periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome in children. The Journal of Pediatrics, 282, 114559. https://doi.org/10.1016/j.jpeds.2025.114559
Hara, M., Morimoto, N., Watabe, T., Morisaki, N., & Matsumoto, K. (2023). Can the effectiveness of tonsillectomy for PFAPA syndrome be predicted based on clinical factors? International Journal of Rheumatic Diseases, 26(3), 480–486. https://doi.org/10.1111/1756-185X.14559
Gozen, E. D., Yildiz, M., Kara, S., Tevetoglu, F., Haslak, F., Adrovic, A., et al. (2023). Long-term efficacy of tonsillectomy/adenotonsillectomy in patients with periodic fever aphthous stomatitis pharyngitis adenitis syndrome with special emphasis on co-existence of familial Mediterranean fever. Rheumatology International, 43(1), 137–145. https://doi.org/10.1007/s00296-022-05210-4
Banh Chong, T., Sagot, O., Alexis, M., Brehin, C., Brochard, K., & Gallois, Y. (2025). Efficacy of partial tonsillectomy in periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome: a STROBE retrospective observational study. European Annals of Otorhinolaryngology, Head and Neck Diseases, 142(3), 115–120. https://doi.org/10.1016/j.anorl.2024.07.010
Karayağmurlu, A., & Aytaç, İ. (2020). Pre- and postoperative quality of life and emotional/behavioural problems in children with PFAPA. International Journal of Pediatric Otorhinolaryngology, 137, 110239. https://doi.org/10.1016/j.ijporl.2020.110239
Bedir, A. G., & Kilic, S. S. (2025). Clinical characteristics and quality of life in children with PFAPA syndrome and Behçet's disease. Rheumatology Advances in Practice, 9(1), rkaf015. https://doi.org/10.1093/rap/rkaf015
Londono, L., Bell, K. J., Stagliano, D. R., & Adams, D. J. (2026). Parent perspectives on the diagnosis, management, and family impact of periodic fever, aphthous stomatitis, pharyngitis, adenitis syndrome. Military Medicine, usag138. https://doi.org/10.1093/milmed/usag138
Otar Yener, G., Aktaş, İ., Altıntaş Meşe, C., & Çakan, M. (2023). Does having MEFV gene sequence variants affect the clinical course and colchicine response in children with PFAPA syndrome? European Journal of Pediatrics, 182(1), 411–417. https://doi.org/10.1007/s00431-022-04709-z
Yildiz, M., Haslak, F., Adrovic, A., Gucuyener, N., Ulkersoy, I., Koker, O., et al. (2021). Independent risk factors for resolution of periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome within 4 years after the disease onset. Clinical Rheumatology, 40(5), 1959–1965. https://doi.org/10.1007/s10067-020-05466-w
Labouret, M., Elhani, I., Cavelot, S., Dingulu, G., Jouret, M., Nguyen, A. T., et al. (2025). Symptom course of PFAPA syndrome. Pediatric Rheumatology, 23(1), 126. https://doi.org/10.1186/s12969-025-01157-5
Benderlioğlu, E., Efeoğlu Gülsoy, G., Özçelik, E., & Çelikel Acar, B. (2026). Perinatal and early childhood determinants of disease persistence in PFAPA. Pediatric Research. https://doi.org/10.1038/s41390-026-05094-1
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Monika Kamela, Adrianna Baran, Olaf Krawczyk, Katarzyna Boszczyk, Norbert Krawczyk, Aleksandra Palka, Natalia Krzysztofek, Wojciech Kopyciński, Małgorzata Grzybowska, Piotr Wilczkowski

This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.

